Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Sarb99on Feb 18, 2021 1:52pm
157 Views
Post# 32597435

Medivolve really wants to stop manipulation

Medivolve really wants to stop manipulation
For a long time, Medivolve stock was manipulated to the max. People who do not even know the ABC of stock trading or research, started acting like a short-selling guru. 
 
Finally, Medivolve should be trading at a fair value. Medivolve is coming out strong by hiring 3 different marketing companies to create awareness. This can effectively deal with relentless manipulation by Anonymous. 
 
Medivolve should be trading over $2 with 100 collection sites up and running. USD 7.1 million revenue alone in January should have been enough for Medivolve to trade over $1. Now, at the end of February collection sites increasing to 107 is about 3x compared to January. 
 
Medivolve also moving into telehealth can be assuring for long-term investment. 
<< Previous
Bullboard Posts
Next >>